Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
ABVX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.8

Margin Of Safety %

Put/Call OI Ratio

0.56

EPS Next Q Diff

0.45

EPS Last/This Y

2.01

EPS This/Next Y

0.79

Price

121.47

Target Price

146.67

Analyst Recom

1.41

Performance Q

1.85

Upside

-256.0%

Beta

0.86

Ticker: ABVX



22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-13ABVX121.50.530.2971186
2026-04-14ABVX125.620.550.3772926
2026-04-15ABVX121.190.550.5675742
2026-04-16ABVX122.390.560.2578658
2026-04-17ABVX120.10.550.3980226
2026-04-20ABVX114.980.540.3464737
2026-04-21ABVX111.460.520.4269397
2026-04-22ABVX115.980.520.1572640
2026-04-23ABVX112.920.511.2874194
2026-04-24ABVX114.540.550.2376850
2026-04-27ABVX112.060.580.4567568
2026-04-28ABVX109.890.590.2270584
2026-04-29ABVX106.240.570.5473358
2026-04-30ABVX117.370.570.3075526
2026-05-01ABVX117.460.540.1879926
2026-05-04ABVX117.210.560.6273595
2026-05-05ABVX123.780.560.2375098
2026-05-06ABVX126.780.530.6081094
2026-05-07ABVX124.640.530.2284894
2026-05-08ABVX122.680.520.4386448
2026-05-11ABVX122.210.520.6980494
2026-05-12ABVX121.870.561.4384270
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1



22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-13ABVX121.47- - -3.63
2026-04-14ABVX125.68- - -3.63
2026-04-15ABVX121.27- - -3.63
2026-04-16ABVX122.37- - -3.63
2026-04-17ABVX120.15- - -3.63
2026-04-20ABVX115.08- - -3.63
2026-04-21ABVX111.53- - -3.63
2026-04-22ABVX115.98- - -3.63
2026-04-23ABVX112.93- - -3.63
2026-04-24ABVX114.52- - -3.63
2026-04-27ABVX111.94- - -3.63
2026-04-28ABVX109.82- - -3.64
2026-04-29ABVX106.35- - -3.64
2026-04-30ABVX117.34- - -3.64
2026-05-01ABVX117.47- - -3.64
2026-05-04ABVX117.12- - -3.64
2026-05-05ABVX123.71- - -3.64
2026-05-06ABVX126.56- - -3.64
2026-05-07ABVX124.66- - -3.64
2026-05-08ABVX122.65- - -3.64
2026-05-11ABVX122.21- - -3.64
2026-05-12ABVX121.47- - -3.64
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1



21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-13ABVX0.00-8.314.91
2026-04-14ABVX0.00-8.314.91
2026-04-15ABVX0.00-8.314.91
2026-04-17ABVX0.00-8.314.91
2026-04-20ABVX0.00-8.024.91
2026-04-21ABVX0.00-8.024.91
2026-04-22ABVX0.00-8.024.90
2026-04-23ABVX0.00-8.024.90
2026-04-24ABVX0.00-8.024.90
2026-04-27ABVX0.00-6.363.84
2026-04-28ABVX0.00-6.363.84
2026-04-29ABVX0.00-6.363.84
2026-04-30ABVX0.00-6.363.84
2026-05-01ABVX0.00-6.363.84
2026-05-04ABVX0.00-5.763.84
2026-05-05ABVX0.00-5.763.84
2026-05-06ABVX0.00-5.763.84
2026-05-07ABVX0.00-5.763.84
2026-05-08ABVX0.00-5.763.84
2026-05-11ABVX0.00-4.983.82
2026-05-12ABVX0.00-4.983.80
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

-1.19

Avg. EPS Est. Current Quarter

-0.81

Avg. EPS Est. Next Quarter

-0.74

Insider Transactions

Institutional Transactions

-4.98

Beta

0.86

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

15

Growth Score

23

Sentiment Score

94

Actual DrawDown %

18.4

Max Drawdown 5-Year %

Target Price

146.67

P/E

Forward P/E

PEG

P/S

P/B

17.83

P/Free Cash Flow

EPS

-5.41

Average EPS Est. Cur. Y​

-3.64

EPS Next Y. (Est.)

-2.85

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.76

Return on Equity vs Sector %

-100.7

Return on Equity vs Industry %

-85.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

◆ ABVX Healthcare
$121.39
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
13/25
Volume
9/15
Valuation
7/20
TP/AR
2/10
Options
3/10
RSI
53.6
Range 1M
65.8%
Sup Dist
1.6%
🚀
Momentum Growth
Ride accelerating trends
N/A
28 /100
WEAK
Momentum
4/25
Growth
17/30
Estimates
0/20
Inst/Vol
2/15
Options
5/10
EPS Yr
27.7%
EPS NY
18.8%
52W%
80.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟡 HOLD +20.8% upside
Quality
2/30
Valuation
6/30
Growth
12/25
Stability
6/10
LT Trend
0/5
Upside
+20.8%
Quality
15
Click a card to see score breakdown Full Analysis →
Abivax SA
Sector: Healthcare
Industry: Biotechnology
Employees: 69
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
ABVX

Latest News

—
Caricamento notizie per ABVX…
stock quote shares ABVX – Abivax ADR Stock Price stock today
news today ABVX – Abivax ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch ABVX – Abivax ADR yahoo finance google finance
stock history ABVX – Abivax ADR invest stock market
stock prices ABVX premarket after hours
ticker ABVX fair value insiders trading